title: [Clinical features of, treatments and preventions for newborns with pandemic influenza A (H1N1) 2009].
abstract: Newborns should be considered to be at high risk of developing complications of novel influenza like pandemic influenza A (H1N1) 2009, because maternal antibodies are not transferred via crossing the placenta. In Japan, some newborns with pandemic influenza A (H1N1) 2009 appeared non-specific symptoms, such as fever, poor activity and sucking, and apnea. A Japanese newborn infected with pandemic influenza A (H1N1) 2009 combined with S. pneumoniae, developed severe pneumonia by which a mechanical ventilation was initiated. Orally oseltamivir(3-4 mg/kg/dose twice a day for 5 days) was used for treatments of flu-infected newborns. Contact and droplet precautions were very important measures to prevent transmission of pandemic influenza A (H1N1) 2009 virus to newborns.
authors.affiliation: Division of Infection Control and Prevention, Kobe University Hospital.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Morioka
authors.forename: Soichi
authors.initials: S
authors.lastname: Arakawa
authors.forename: Masafumi
authors.initials: M
authors.lastname: Matsuo
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy* / Q000635:transmission; D053139:Oseltamivir / Q000008:administration & dosage; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000628:therapy; D012121:Respiration, Artificial; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir